Literature DB >> 31517721

Expression of Lubricin in the Human Amniotic Membrane.

Jingyi Wang1,2, Di Chen1,2, David A Sullivan1, Huatao Xie1,3, Ying Li2, Yang Liu1.   

Abstract

PURPOSE: Lubricin, a boundary lubricant, is the body's unique antiadhesive, antifibrotic, antifriction, and antiinflammatory glycoprotein. This amphiphile is produced by numerous tissues and acts to regulate a number of processes, such as homeostasis, shear stress, tissue development, innate immunity, inflammation, and wound healing. We hypothesize that lubricin is also synthesized and expressed by the amniotic membrane (AM), which also possesses antiadhesive, antifibrotic, and antiinflammatory properties. We also hypothesize that lubricin, at least in part, mediates these AM capabilities. Our goal was to test our hypothesis.
METHODS: We obtained multiple samples of fresh, cryopreserved (CP), and freeze-dried (FD) human AMs, as well as fresh placental tissue as positive controls, and processed them for light microscopy, immunofluorescence, and western blot analyses. We also evaluated the ability of recombinant human lubricin to associate with FD-AMs.
RESULTS: Our results demonstrate that all fresh placental, fresh AM, and CP-AM samples contained lubricin. Lubricin was expressed in placental chorionic villi, AM epithelial and stromal cells, and CP-AM epithelia. No lubricin could be detected in FD-AMs but could be restored in FD-AMs after overnight incubation with recombinant human lubricin.
CONCLUSIONS: This study supports our hypothesis that lubricin is expressed in human AMs. In addition, our data show that preservation methods influence the extent of this expression. Indeed, the disappearance of lubricin in FD-AMs may explain why dried AM reportedly loses its antiinflammatory and antiscarring abilities. It is possible that lubricin may mediate, at least in part, many of the biological properties of AMs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31517721      PMCID: PMC6893128          DOI: 10.1097/ICO.0000000000002151

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   3.152


  35 in total

1.  Severe fibrosis of extraocular muscles after the use of lyophilized amniotic membrane in strabismus surgery.

Authors:  Rehab R Kassem; Ghada I Gawdat; Rasha H Zedan
Journal:  J AAPOS       Date:  2010-12       Impact factor: 1.220

2.  The use of amniotic membrane in reducing adhesions after strabismus surgery.

Authors:  Hosam Sheha; Victoria Casas; Yasutaka Hayashida
Journal:  J AAPOS       Date:  2008-10-30       Impact factor: 1.220

3.  Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.

Authors:  Meilang Xue; Kelly McKelvey; Kaitlin Shen; Nikita Minhas; Lyn March; Sang-Youel Park; Christopher J Jackson
Journal:  Rheumatology (Oxford)       Date:  2014-06-29       Impact factor: 7.580

Review 4.  Amniotic Membrane Transplantation in Strabismus Surgery.

Authors:  Rehab Rashad Kassem; Randa Mohamed Abdel-Moneim El-Mofty
Journal:  Curr Eye Res       Date:  2019-01-28       Impact factor: 2.424

5.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

6.  Two compartment pharmacokinetic model describes the intra-articular delivery and retention of rhprg4 following ACL transection in the Yucatan mini pig.

Authors:  Mark Hurtig; Iman Zaghoul; Heather Sheardown; Tannin A Schmidt; Lina Liu; Ling Zhang; Khaled A Elsaid; Gregory D Jay
Journal:  J Orthop Res       Date:  2018-12-17       Impact factor: 3.494

7.  Implantation of amniotic membrane to reduce postlaminectomy epidural adhesions.

Authors:  Huiren Tao; Hongbin Fan
Journal:  Eur Spine J       Date:  2009-04-30       Impact factor: 3.134

Review 8.  The biology of lubricin: near frictionless joint motion.

Authors:  Gregory D Jay; Kimberly A Waller
Journal:  Matrix Biol       Date:  2014-08-27       Impact factor: 11.583

Review 9.  Human amniotic membrane transplantation: Different modalities of its use in ophthalmology.

Authors:  Chintan Malhotra; Arun K Jain
Journal:  World J Transplant       Date:  2014-06-24

10.  Recombinant human proteoglycan-4 reduces phagocytosis of urate crystals and downstream nuclear factor kappa B and inflammasome activation and production of cytokines and chemokines in human and murine macrophages.

Authors:  Marwa Qadri; Gregory D Jay; Ling X Zhang; Wendy Wong; Anthony M Reginato; Changqi Sun; Tannin A Schmidt; Khaled A Elsaid
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

View more
  2 in total

1.  Intra-Articular Adeno-Associated Virus-Mediated Proteoglycan 4 Gene Therapy for Preventing Posttraumatic Osteoarthritis.

Authors:  Dongrim Seol; Hyeong Hun Choe; Hongjun Zheng; Marc J Brouillette; Douglas C Fredericks; Emily B Petersen; Ino Song; Leela R J Chakka; Aliasger K Salem; James A Martin
Journal:  Hum Gene Ther       Date:  2022-01-07       Impact factor: 4.793

Review 2.  Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective.

Authors:  Andrew Walkden
Journal:  Clin Ophthalmol       Date:  2020-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.